Esther Rajavelu, See Remarks at Spero Therapeutics, Inc. (SPRO), sold 87,917 shares at $2.36 ($207K) on 2026-02-06, disclosed to the SEC on 2026-02-09.
Open-market sale of $207k SPRO by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.36 | 37,101 | $88K | 42.2% |
| 2 | $2.36 | 50,816 | $120K | 57.8% |
| Total | $2.36 avg | 87,917 | $207K | 100% |
| Filing → |
| SPRO | SELL | 2025-11-12 | $191K | — | Filing → |
| SPRO | SELL | 2025-02-05 | $16K | — | Filing → |
| SPRO | SELL | 2024-11-12 | $53K | — | Filing → |